Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Adherence Rate in Patients Receiving PegIntron Pen / Rebetol for Hepatitis C

NCT00705107 is registered in ClinicalTrials.gov with Merck Sharp & Dohme LLC as lead sponsor.

NCT NCT00705107
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00705107 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Adherence Rate in Patients Receiving PegIntron Pen / Rebetol for Hepatitis C
Lead sponsor
Merck Sharp & Dohme LLC
Phase
Observational
Overall status
Terminated
Start date
November 30, 2004
Completion date
November 30, 2007
Enrollment
267 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis c, hepatitis c, chronic